fibrosis. Expression of E-cadherin and α-SMA in kidney tissue was also evaluated by western blot analysis for the analysis of epithelia-mesenchymal transition (EMT). Level of transforming growth factor-beta1 (TGF-β1) in the serum and kidney tissues at 6 months after injury was determined by enzyme-linked immunosorbent assay. Results: Fleshly isolated SVF expressed hematopoietic, mesenchymal, and endothelial antigens. Higher cell retention rate was detected in SVF pre-ischemic administration group. SVF pre-ischemic administration showed stronger functional and morphologic protection from renal IR injury than SVF post-ischemic administration by enhancing tubular epithelial cell proliferation and reducing apoptosis. Progression of chronic kidney damage was also significantly delayed by pre-ischemic administration of SVF, compare with post-ischemic administration, through inhibiting EMT, microvascular rarefaction, and the production of TGF-β1. In addition, in vitro study showed that SVF pre-hypoxic administration could also significantly promote the proliferation, migration and survival of hypoxic renal tubular epithelial cells. Conclusions: Our study firstly demonstrated that preadministration of uncultured adipose SVF protect the kidney from both early IR injury and long-term risk of developing CKD. SVF administration before ischemia could enhance cell retention and then contributed to the improvement of tubular epithelial cells survival and proliferation, and inhibition of CKD. 
and long-term protective effect of uncultured adipose stromal vascular fraction against renal ischemia-reperfusion injury via pre-ischemic administration. Transl Androl Urol 2016;5(Suppl Abstract: Self-renewal and differentiation of endogenous stem cells (SCs) are essential for adult tissue homoeostasis and intrinsic healing capacity. Here, we hypothesize that penis contains a small population of endogenous SCs which might help rejuvenation of damaged erectile function. In this study, 60 newborn male rats were intraperitoneally injected with 5-ethynyl-2-deoxyuridine (EdU; 50 mg) for the purpose of tracking endogenous SCs. Twelve weeks later, 48 rats underwent bilateral cavernous nerves (CN) injury and were randomized into gavage feeding of solvent (vehicle group) or icariside II (ICAII) (0.5, 1.5 and 4.5 mg per day, respectively). Twelve sham-operated rats received vehicle treatment and served as control. The treatments were continued for 4 weeks followed by a washout period of 72 h. Results showed that ICAII treatment significantly restored erectile function and effectively prevented distortion of normal neural anatomy, smooth muscle atrophy and collagen deposition compared to vehicle group. The numbers of label retaining cells (LRCs) co-expressing EdU and differentiated phenotypes (smooth muscle markerα-SMA or Schwann cell marker S100) were significantly higher in three ICAII-treated groups than those in vehicle group in a dose-dependent manner. In addition, the changing trend of p38 mitogen activated protein kinase (MAPK) activity in the penis between groups was same as that of the number of differentiated LRCs. Together, these results suggest that the underlying mechanisms of ICAII in ameliorating erectile function and pathological changes appear to involve enhanced endogenous SCs differentiation, which might be regulated by p38 MAPK signaling pathway. 
